Marcaine/epinephrine 0.5% Inj, 30ml
Overview
What is this medicine?
How to Use This Medicine
To use this medication correctly, follow your doctor's instructions and read all the information provided. It is essential to follow the instructions carefully. This medication is administered via injection.
Storage and Disposal
This medication will be administered in a hospital or doctor's office, so you will not need to store it at home.
Missed Dose
Since this medication is given as needed in a healthcare setting, you will not need to worry about missing a dose. The healthcare provider will administer the medication according to your individual needs.
Lifestyle & Tips
- Report any unusual symptoms immediately during or after the procedure.
- Avoid activities requiring fine motor skills or full sensation until the numbing effect has completely worn off (e.g., driving, operating machinery, handling hot objects).
- Protect the numb area from injury (e.g., burns, cuts) as you won't feel pain.
Available Forms & Alternatives
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
BLACK BOX WARNING
Side Effects
Although rare, this medication can cause severe and potentially life-threatening side effects. If you experience any of the following symptoms, contact your doctor or seek medical attention right away:
Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of acidosis (too much acid in the blood), such as:
+ Confusion
+ Fast breathing
+ Fast heartbeat
+ Irregular heartbeat
+ Severe stomach pain, nausea, or vomiting
+ Excessive sleepiness
+ Shortness of breath
+ Feeling extremely tired or weak
Signs of methemoglobinemia, a rare but potentially deadly condition, such as:
+ Blue or gray discoloration of the lips, nails, or skin
+ Irregular heartbeat
+ Seizures
+ Severe dizziness or fainting
+ Severe headache
+ Excessive sleepiness
+ Feeling extremely tired or weak
+ Shortness of breath
Other serious side effects, such as:
+ Feeling extremely hot or cold
+ Dizziness or fainting
+ Lightheadedness, sleepiness, confusion, or blurred vision
+ Balance problems
+ Restlessness
+ Anxiety
+ Changes in speech
+ Numbness or tingling in the mouth
+ Metallic taste
+ Ringing in the ears
+ Shakiness
+ Twitching
+ Seizures
+ Breathing difficulties, slow breathing, or shallow breathing
+ Abnormal sensations, such as burning, numbness, or tingling
+ Feeling nervous and excitable
+ Headache
+ Severe nausea or vomiting
+ Abnormal heartbeat, chest pain, or pressure
+ Fever or chills
+ Sneezing
+ Excessive sweating
+ Skin reactions, such as burning, color changes, pain, skin breakdown, or swelling at the injection site
* Spinal-related side effects, such as:
+ Urination difficulties
+ Loss of bladder or bowel control
+ Erectile dysfunction
+ Long-lasting burning, numbness, tingling, or paralysis in the lower half of the body
+ Back pain
+ Stiff neck
+ Sensitivity to light
Other Side Effects
Most medications can cause side effects, but many people experience none or only mild symptoms. If you have any side effects that bother you or persist, contact your doctor for advice. This is not an exhaustive list of possible side effects. If you have questions or concerns, discuss them with your doctor.
Reporting Side Effects
You can report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Dizziness, lightheadedness, or feeling faint
- Ringing in the ears (tinnitus)
- Numbness or tingling around the mouth
- Blurred vision or double vision
- Tremors or muscle twitching
- Feeling anxious, restless, or confused
- Difficulty breathing or shortness of breath
- Slow or fast heartbeat, palpitations
- Chest pain
- Unusual weakness or drowsiness
- Seizures
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction you experienced, including any symptoms that occurred.
Certain health conditions, including:
+ Bleeding disorders
+ Abnormal heart rhythms
+ Blood infections or infections at the site where the medication will be administered
+ Low blood pressure (hypotension)
If you are taking any of the following medications:
+ Antidepressants like isocarboxazid, phenelzine, or tranylcypromine
+ Medications for Parkinson's disease, such as selegiline or rasagiline
+ Tricyclic antidepressants, including amitriptyline, amoxapine, clomipramine, desipramine, doxepin, imipramine, nortriptyline, protriptyline, or trimipramine
+ Beta blockers, such as nadolol, propranolol, sotalol, or timolol
All your medications, including prescription and over-the-counter (OTC) drugs, natural products, and vitamins. This is not an exhaustive list, and it is crucial to discuss all your medications and health conditions with your doctor to ensure safe use.
Remember to consult your doctor and pharmacist before taking this medication to verify that it is safe to use with your existing medications and health conditions. Do not initiate, stop, or adjust the dosage of any medication without first consulting your doctor.
Precautions & Cautions
When taking this medication, it is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are using this drug.
To ensure your safety, avoid driving and engaging in activities that require alertness until the effects of the medication have worn off and you feel fully awake.
If you have a sulfite allergy, consult your doctor, as some products contain sulfites.
There is a risk of developing a severe blood condition called methemoglobinemia with this medication. This risk may be increased in individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency, heart problems, or lung problems. Additionally, the risk may be higher when taking certain other medications or in infants under 6 months of age. If you have a history of methemoglobinemia, inform your doctor.
If you are 65 years or older, use this medication with caution, as you may be more susceptible to side effects.
Not all products are suitable for children, so consult your doctor before administering this medication to a child.
If you are pregnant, plan to become pregnant, or are breastfeeding, discuss the benefits and risks of this medication with your doctor to make an informed decision.
Mouth (Local Anesthesia)
While your mouth is numb, avoid eating to prevent accidentally biting your tongue.
Spinal (Regional Anesthesia)
This medication may cause temporary loss of sensation and motor function in the lower half of your body. Until feeling and motor function have returned to normal, do not attempt to get out of bed or engage in any activities that require mobility.
Overdose Information
Overdose Symptoms:
- Severe dizziness or lightheadedness
- Confusion, disorientation
- Slurred speech
- Severe tremors or muscle twitching progressing to seizures
- Unconsciousness
- Respiratory arrest (stopping breathing)
- Severe low blood pressure (hypotension)
- Slow heart rate (bradycardia)
- Irregular heartbeats (arrhythmias)
- Cardiac arrest
What to Do:
Overdose is a medical emergency. Immediately call 911 or your local emergency number. If you are with someone who has overdosed, call 911. Management typically involves airway management, oxygenation, ventilatory support, IV fluids, vasopressors for hypotension, benzodiazepines for seizures, and lipid emulsion therapy for severe local anesthetic systemic toxicity (LAST). Call 1-800-222-1222 (Poison Control Center) for additional guidance.
Drug Interactions
Contraindicated Interactions
- Not for intravenous regional anesthesia (Bier block) due to risk of cardiac arrest.
- 0.75% Bupivacaine is contraindicated for obstetrical epidural anesthesia due to risk of intractable cardiac arrest.
Major Interactions
- Other local anesthetics (additive systemic toxicity)
- Antiarrhythmics (e.g., Class I antiarrhythmics like lidocaine, mexiletine, tocainide - additive cardiac effects)
- Monoamine Oxidase Inhibitors (MAOIs) (e.g., phenelzine, tranylcypromine - potentiate pressor effects of epinephrine, leading to hypertensive crisis)
- Tricyclic Antidepressants (TCAs) (e.g., amitriptyline, imipramine - potentiate pressor effects of epinephrine, leading to hypertensive crisis)
- Non-selective Beta-blockers (e.g., propranolol, nadolol - can lead to severe hypertension followed by bradycardia due to unopposed alpha-adrenergic effects of epinephrine)
- Ergot-type oxytocic drugs (e.g., ergonovine, methylergonovine - severe persistent hypertension or cerebrovascular accidents when used with vasoconstrictors like epinephrine)
- Inhalation anesthetics (e.g., halothane, isoflurane - sensitize myocardium to epinephrine, increasing risk of arrhythmias)
Moderate Interactions
- Alpha-adrenergic blocking agents (e.g., prazosin, tamsulosin - may reduce vasoconstrictive effect of epinephrine)
- Phenothiazines and other antipsychotics (e.g., chlorpromazine - may reverse pressor effect of epinephrine)
- Thyroid hormones (may increase sensitivity to catecholamines like epinephrine)
- Digitalis glycosides (increased risk of arrhythmias with epinephrine)
Minor Interactions
- Not available
Monitoring
Baseline Monitoring
Rationale: To identify contraindications, risk factors for toxicity (e.g., cardiac, hepatic, renal disease), and assess overall health status.
Timing: Prior to administration
Rationale: To establish baseline and detect early signs of systemic toxicity or adverse reactions to epinephrine.
Timing: Prior to administration
Rationale: To identify hypersensitivity to amide-type local anesthetics, sulfites (present in some epinephrine formulations), or other components.
Timing: Prior to administration
Routine Monitoring
Frequency: Every 5-15 minutes during and immediately after injection, then as clinically indicated.
Target: Within patient's normal physiological range, or as per institutional protocol.
Action Threshold: Significant deviations (e.g., hypotension, bradycardia, tachycardia, hypertension, desaturation) warrant immediate investigation and intervention.
Frequency: Continuously during and after injection.
Target: Normal mentation, absence of CNS excitatory or depressive symptoms.
Action Threshold: Any new or worsening CNS symptoms (e.g., lightheadedness, confusion, seizures) indicate potential systemic toxicity.
Frequency: Continuous during and immediately after injection.
Target: Normal sinus rhythm, absence of arrhythmias.
Action Threshold: Arrhythmias (e.g., bradycardia, ventricular ectopy, wide QRS, asystole) indicate severe cardiac toxicity.
Symptom Monitoring
- Lightheadedness
- Dizziness
- Tinnitus
- Perioral numbness
- Metallic taste
- Blurred vision
- Tremors
- Muscle twitching
- Seizures
- Drowsiness
- Unconsciousness
- Respiratory depression/arrest
- Bradycardia
- Hypotension
- Hypertension
- Tachycardia
- Palpitations
- Arrhythmias
- Chest pain
- Anxiety
- Restlessness
- Nausea/vomiting
Special Patient Groups
Pregnancy
Category C. Use only if the potential benefit justifies the potential risk to the fetus. Bupivacaine crosses the placenta. Epinephrine can affect uterine blood flow and contractility.
Trimester-Specific Risks:
Lactation
Bupivacaine is excreted into breast milk in small amounts (L2 - probably compatible). Epinephrine is rapidly metabolized and unlikely to be present in breast milk in significant amounts (L1 - compatible). Generally considered safe for breastfeeding mothers when used appropriately.
Pediatric Use
Use with extreme caution, especially in infants and young children, due to higher risk of systemic toxicity from lower body weight, immature hepatic metabolism, and potential for relative overdose. Dosing must be carefully calculated on a mg/kg basis. Avoid in neonates and infants unless absolutely necessary and with expert supervision.
Geriatric Use
Use with caution. Elderly patients may be more susceptible to systemic toxicity due to decreased hepatic function, reduced renal clearance of metabolites, and altered body composition. Start with lower doses and titrate slowly. Monitor closely for CNS and cardiovascular adverse effects.
Clinical Information
Clinical Pearls
- Always aspirate prior to injection to avoid inadvertent intravascular administration, which can lead to severe systemic toxicity (LAST).
- The presence of epinephrine prolongs the duration of action and reduces systemic absorption, but also adds the risk of epinephrine-related side effects (e.g., tachycardia, hypertension, anxiety, myocardial ischemia, especially in patients with cardiovascular disease).
- Bupivacaine has a higher potential for cardiotoxicity compared to other local anesthetics like lidocaine. Resuscitation from bupivacaine-induced cardiac arrest can be challenging and may require lipid emulsion therapy.
- Do not use formulations containing epinephrine in areas with end-arterial supply (e.g., fingers, toes, nose, penis, earlobe) due to risk of ischemia and necrosis.
- Carefully consider the total dose of both bupivacaine and epinephrine, especially in smaller patients or those with comorbidities.
- Always have resuscitation equipment and medications (e.g., lipid emulsion, vasopressors, benzodiazepines) readily available when administering bupivacaine.
Alternative Therapies
- Lidocaine (shorter duration, less cardiotoxic)
- Ropivacaine (less cardiotoxic than bupivacaine, similar duration)
- Levobupivacaine (S-enantiomer of bupivacaine, potentially less cardiotoxic)
- Tetracaine (ester-type, longer duration, topical/spinal use)
- Chloroprocaine (ester-type, very short duration)
- General anesthesia
- Regional nerve blocks without vasoconstrictor (shorter duration)
- Non-pharmacological pain management techniques